Who are Oxygen/nitrous oxide equimolar mix's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/oxygen-nitrous-oxide-equimolar-mix.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Oxygen/nitrous oxide equimolar mix — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oxygen/nitrous oxide equimolar mix (Oxygen/nitrous oxide equimolar mix) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inhalational anesthetic/analgesic gas mixture. Area: Anesthesia; Acute Pain Management.

marketed Inhalational anesthetic/analgesic gas mixture NMDA receptor antagonist; endogenous opioid system modulation Anesthesia; Acute Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Oxygen/nitrous oxide equimolar mix (Oxygen/nitrous oxide equimolar mix) — Hospital St. Joseph, Marseille, France. An equimolar mixture of oxygen and nitrous oxide provides rapid analgesia and anxiolysis through nitrous oxide's effects on central nervous system receptors while maintaining adequate oxygenation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Oxygen/nitrous oxide equimolar mix TARGET	Oxygen/nitrous oxide equimolar mix	Hospital St. Joseph, Marseille, France	marketed	Inhalational anesthetic/analgesic gas mixture	NMDA receptor antagonist; endogenous opioid system modulation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inhalational anesthetic/analgesic gas mixture class)

Hospital St. Joseph, Marseille, France · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxygen/nitrous oxide equimolar mix — Competitive Intelligence Brief. https://druglandscape.com/ci/oxygen-nitrous-oxide-equimolar-mix. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab